Your browser version may not work well with NCBI's Web applications. More information here...
1: P R Health Sci J. 2004 Jun;23(2):115-8.Links

Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.

Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.

Center for the Improvement of Human Functioning, RENAC Project, Wichita, KS, USA.

A series of seven cases are presented in which intravenous vitamin C has been used as antineoplastic agent in the treatment of different types of cancers. The cancers cases reviewed are the following: Renal cell carcinoma (2), Colorectal cancer (1), Pancreatic cancer (1), Non-Hodgkin's lymphoma (2) and breast cancer (1). Toxic reactions were not observed at these high doses of intravenous Vitamin C. All patients were prescreened for Glucose 6--phosphate dehydrogenase deficiency before administering intravenous Vitamin C in order to prevent hemolysis.

PMID: 15377059 [PubMed - indexed for MEDLINE]

Patient Drug Information